Fundraising Fox
🦊/People
Sign in

Milton H. Werner

Founder

Chief Executive Officer, President, and Secretary at ABLi Therapeutics · Founder at Inhibikase Therapeutics

Greater Boston

FoundedABLi TherapeuticsInhibikase Therapeutics

Find your path to Milton

294 people in our graph share verified history with Milton — schools, employers, funds. One of them is your warm intro.

Mojca SkoberneunlockedMilton: together at Rockefeller University (2002–2003)
×11Milton: together at University of California, Berkeley

Chief Executive Officer, President, and Secretary at ABLi Therapeutics

Founder at Inhibikase Therapeutics

Intro paths

→

In turn, Milton can intro founders to Inhibikase Therapeutics's investors below.

Inhibikase Therapeutics's investors · 1

National Institutes of Health (NIH)since 2016

Experience

  1. ABLi Therapeutics, Inc.Founder, Chairperson & CEOcurrent2025 — present
  2. Inhibikase TherapeuticsFounder, President & CEO2008 — 2025Atlanta, Georgia and Boston, Massachusetts
  3. Celtaxsys, Inc.Vice-President, Discovery Research2007 — 2008
  4. Rockefeller UniversityAssociate Professor/Head of Laboratory1996 — 2007

Skills & more

Pharmaceutical IndustryTherapists

Languages French · Spanish

From Milton's professional profile.

Frequently asked questions

Who is Milton H. Werner?
Chief Executive Officer, President, and Secretary at ABLi Therapeutics
Where does Milton H. Werner work?
Milton H. Werner is Chief Executive Officer, President, and Secretary of ABLi Therapeutics and Co-founder at Inhibikase Therapeutics.
What companies did Milton H. Werner found?
Milton H. Werner founded ABLi Therapeutics, Inhibikase Therapeutics.
Where did Milton H. Werner go to school?
Milton H. Werner studied at University of California, Berkeley (PhD, Chemistry, Biochemistry, Biophysics); University of Southern California (Bachelor of Science - BS, Biological and Physical Sciences).

Founder mafias

Same school

Shared employers